A modified tRNA therapy bypassed premature genetic stop signals and restored working proteins in cystic fibrosis disease models.

Tevard Biosciences, Inc., a biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today highlighted the publication of research conducted by scientists at ...

Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment ...

Between 10 to 15% of all genetic diseases have the same underlying cause: a nonsense mutation. 1 This type of mutation results from a stop codon in the middle of a gene sequence, which terminates ...

A methylation marker on the tRNA, and a new lipid nanoparticle, helps the ribosome ignore disease-causing mutations ...

For decades, biology students have learned one rule about the genetic code that supposedly has no exceptions: three specific DNA sequences act as stop signs, telling the cell’s protein-building ...

Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause various diseases. However, other approaches achieve the same effect without ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian cells, researchers from Peking University led by Chen Peng from College of ...